• The Susan F. Smith Center for Women's Cancers at Dana-Farber unites many of the world's leading experts in breast and gynecologic cancers with one common goal: to give all women the latest, most advanced care, including innovative therapies that are often available only through clinical trials.

    A place of hope and action, the Susan F. Smith Center for Women's Cancers offers multi-dimensional services to strengthen mind, body, and soul and to help alleviate mental and emotional burdens. Ending women's cancers are the reason we exist. Everything we do – from the moment a patient pulls into the parking lot until the moment they leave the building after their last treatment – is tailored to the unique needs of women.

  • The Susan F. Smith Center for Women's Cancers began as an idea to unite the clinical and research strengths of the breast and gynecologic cancer programs. This notion of a center dedicated to studying and treating all women's cancers captured Dana-Farber Trustee Susan F. Smith's imagination. Her determination to make the center a reality — along with the strong support of many other individuals and organizations — has been a steady force behind its growth.

    Today, we are pushing the frontier of research for women's cancers by developing innovative therapies and setting cancer care standards for other physicians across the country and around the world.

    Strengthening collaborations

    The Susan F. Smith Center was designed to increase opportunities for scientific collaboration. Physicians and scientists don’t have to travel far to meet: an enclosed bridge connects clinical care with corresponding research facilities in the Richard A. and Susan F. Smith Research Laboratories next door. The proximity promotes translational research that converts scientific advances into new treatments.

    The Susan F. Smith Center at Dana-Farber shares advances in cancer research and treatment with the healthcare community through continuing medical education courses.

    Learn more about continuing medical education.

    Accolades and awards

    Highlights of the work of the Susan F. Smith Center for Women's Cancers include:

    • The Dana-Farber/Harvard Cancer Center Men's Collaborative to Cure Women's Cancers delivered its first round of funding to support five projects aimed at uncovering new information about the ways cancer cells respond or develop resistance to chemotherapy.
    • Kornelia Polyak, MD, PhD, received the Paul Marks Prize for Cancer Research, a biennial award honoring young scientists for their contributions to cancer research.
    • The PI3 kinase "Dream Team," which includes a mix of researchers and clinicians specializing in breast and gynecologic cancers, was chosen to receive continued funding from Stand Up To Cancer (SU2C), a national non-profit organization supporting research initiatives. The team will further explore how to shut down the P13 kinase protein that allows cancer to grow.
    • President Barack Obama appointed Judy Garber, MD, MPH, to the National Cancer Advisory Board.
    • The Susan F. Smith Center marked a decade of presenting its annual course on controversies and new horizons in breast cancer. The educational event, now led by Harold Burstein, MD, PhD, attracts hundreds of breast cancer clinicians from around the world.